Ann: Changes to the Board of Directors, page-8

I must say the announcement certainly didnt mince words.
"The changes have been made as part of the company’s preparation for commercialisation of
its Cell Penetrating Peptide platform on the back of a series of major technical milestones
scheduled for delivery between now and mid-2019. The milestones will address the critical
question of the efficacy of the company’s platform in animal models of human disease across a
range of drug cargoes and target tissues."

Never heard them talk that directly before.... major milestones between now and mid 2019 in th heir quest to commercialise. No more running trials and see what happens might be another few years. They seem to think it is about to go off. It will be absolutely fascinating to see how it plays out as surely with the holdings the directors have the end game would have to be a direct sale ?? If they start selling on market gradually it would surely tank unless it has gone absolutely crazy already.